Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

AstraZeneca PLC

AZN•NYSE
Healthcare
Drug Manufacturers - General
$208.62
$2.17(1.05%)
U.S. Market opens in 0h 10m

AstraZeneca PLC (AZN) Stock Overview

Explore AstraZeneca PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap633.8B
P/E Ratio62.07
EPS (TTM)$6.53
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$231.98
3 Months$89.26
1 Year Target$92.25

AZN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AstraZeneca PLC (AZN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 82.15, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $92.25.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 62.07 and a market capitalization of 633.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.87%
5-Day Change
-0.48%
1-Month Change
11.71%
3-Month Change
15.07%
6-Month Change
29.70%
Year-to-Date (YTD) Change
12.03%
1-Year Change
40.68%
3-Year Change
45.64%
5-Year Change
100.22%
All-Time (Max) Change
3960.71%

Contact Information

https://www.astrazeneca.com
44 20 3749 5000
1 Francis Crick Avenue, Cambridge, NaN, CB2 0AA

Company Facts

943,000 Employees
IPO DateMay 12, 1993
CountryGB
Actively Trading

Frequently Asked Questions